Cardiovascular Risk Predictors in Patients With Psoriasis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-01

Study Completion Date

2024-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are planning to find the right modification of traditionally used risk scores (PASI, DLQI) in patients with psoriasis of different severity to guide the treatment that could potentially extend life, improve cardiovascular outcomes and quality of life in patients with psoriasis and cardiovascular risk factors in a prospective observational study. The traditionally excluded groups of older patients with diabetes mellitus, decreased kidney function and those with potentially worse prognosis are going to be included in the study. As it's known, the number of those patients is on the rise each year and require a close attention of multidisciplinary teams.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Is Our Microbiome a Predictor of Cardiac Risk

NCT02013284

Coronary Artery Disease

ENROLLING_BY_INVITATION

Polygenic Risk Score for Optimizing Primary Prevention in Intermediate-Risk Populations

NCT07039123

Primary Prevention of Cardiovascular Disease

RECRUITING NA

Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk

NCT00613158

Atherosclerosis Cardiovascular Diseases

COMPLETED

Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

NCT06122961

Cardiovascular Risk Heart Failure Chronic Kidney Disease

COMPLETED

Prediction of Primary Cardiovascular Events Using the Multimarker Approach

NCT05704569

Cardiovascular Diseases Stroke Myocardial Infarction +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psoriasis Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mild psoriasis

No interventions assigned to this group

Moderate psoriasis

No interventions assigned to this group

Severe psoriasis

No interventions assigned to this group

Patients without psoriasis

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age over 18 years
* Written informed consent of the patient to participate in the study

Exclusion Criteria

* Age under 18
* Pregnancy, lactation
* Very high cardiovascular risk
* Life-threatening, independently influencing prognosis and disabling diseases,
* Mental disorders that do not allow to give informed consent or answer questions adequately
* Refuse of the patient to participate in the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes